Trial Profile
Efficacy and safety of silodosin and tamulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2011
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 08 Feb 2011 New trial record